Repurposing Non-Infectious Therapeutic Agents to Aid in the Treatment of Chronic Biofilm Infections

Lila Berle1,2, Yash Sodhi3, Poonam Mathur4

  • 1University of Maryland School of Medicine, Baltimore, MD 21201, USA.

Insights

Novel therapeutics are needed to combat biofilms in chronic infections, as antibiotics are less effective. Repurposing existing safe drugs offers a promising strategy to develop new adjuvant biofilm treatments.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Antibiotics are less effective against microbial biofilms, which are implicated in up to 70% of chronic infections.
  • Biofilm-dwelling microbes require significantly higher antibiotic concentrations (up to 1000x) compared to planktonic forms.
  • There is a critical need for novel therapeutic strategies to effectively treat chronic biofilm infections.

Purpose of the Study:

  • To explore the potential of repurposing existing drugs as adjuvant therapies for chronic biofilm infections.
  • To identify and discuss four drugs with theoretical promise for treating biofilm infections.
  • To highlight the advantages of using already-approved drugs for expedited clinical development.

Main Methods:

  • Reviewing current clinical applications of selected drugs.
  • Investigating potential antimicrobial mechanisms of action for each drug.
  • Compiling existing data supporting their use as adjuvant biofilm agents.

Main Results:

  • Four drugs were identified with theoretical promise as adjuvant biofilm agents.
  • Detailed discussions included current clinical use and proposed antimicrobial activities.
  • Evidence was presented to support their potential role in combating biofilms.

Conclusions:

  • Repurposing safe, non-antimicrobial drugs is a viable strategy for developing new biofilm infection treatments.
  • Clinicians need greater awareness of the antimicrobial potential of commonly used medications.
  • Further research and clinical trials are warranted to validate these repurposed drugs as adjuvant biofilm therapies.

Related Concept Videos

Biofilms01:29

Biofilms

Biofilms are complex communities of microorganisms encased in a self-produced extracellular polysaccharide matrix attached to surfaces. These microbial consortia can include single or multiple species, providing enhanced survival benefits by forming organized, multilayered structures.The formation of biofilms occurs through four key stages: attachment, colonization, development, and dispersal.During attachment, free-swimming planktonic cells adhere to a surface, often facilitated by...
Biological Methods for Microbial Control01:28

Biological Methods for Microbial Control

Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...